p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population

Cancer Letters

Volumn 287, Issue 1, 2010, Pages 117-121

  Ye, Feng ^a,b   Zhang, Jing ^b   Cheng, Qi ^a   Shen, Jiajie ^a   Chen, Huaizeng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Womens Hospital   (China)

Author keywords

Cervical carcinoma; p53 Codon 72 proline; Single nucleotide polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CODON; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CODON; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 72049120366     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.06.004     Document Type: Article

References (22)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
2. Giuliano A.R., Harris R., Sedjo R.L., Baldwin S., Roe D., Papenfuss M.R., Abrahamsen M., Inserra P., Olvera S., and Hatch K. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health Study. J. Infect. Dis. 186 (2002) 462-469
3. Storey, Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I.M., Matlashewski G., and Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
4. Hamel N., Black M.J., Ghadirian P., and Foulkes W.D. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Brit. J. Cancer 82 (2000) 757-759
5. Ngan H.Y., Liu V.W., and Liu S.S. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Brit. J. Cancer 80 (1999) 1828-1829
6. Giannoudis A., Graham D.A., Southern S.A., and Herrington C.S. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int. J. Cancer 83 (1999) 66-69
7. Minaguchi T., Kanamori Y., Matsushima M., Yoshikawa H., Taketani Y., and Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 58 (1998) 4585-4586
8. Dokianakis D.N., and Spandidos D.A. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol. Cell Biol. Res. Commun. 3 (2000) 111-114
9. Zehbe I., Voglino G., Wilander E., Genta F., and Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354 (1999) 218-219
10. Yamashita T., Yaginuma Y., Saitoh Y., Kawai K., Kurakane T., Hayashi H., and Ishikawa M. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis 20 (1999) 1733-1736
11. Zehbe I., Voglino G., Wilander E., Delius H., Marongiu A., Edler L., Klimek F., Andersson S., and Tommasino M. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 61 (2001) 608-611
12. Lanham S., Campbell I., Watt P., and Gornall R. p53 polymorphism and risk of cervical cancer. Lancet 352 (1998) 1631
13. Rosenthal A.N., Ryan A., Al-Jehani R.M., Storey A., Harwood C.A., and Jacobs I.J. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352 (1998) 871-872
14. Helland A., Langerod A., Johnsen H., Olsen A.O., Skovlund E., and Borresen-Dale A.L. p53 polymorphism and risk of cervical cancer. Nature 396 (1998) 530-531 (author reply 532)
15. Helland A., Langerød A., Johnsen H., Olsen A.O., Skovlund E., and Børresen-Dale A.L. p53 polymorphism and risk of cervical cancer. Nature 396 (1998) 531 (author reply 532)
16. Hildesheim A., Schiffman M., Brinton L.A., Fraumeni Jr. J.F., Herrero R., Bratti M.C., Schwartz P., Mortel R., Barnes W., Greenberg M., L cGowan M., Scott D.R., Martin M., Herrera J.E., and Carrington M. p53 polymorphism and risk of cervical cancer. Nature 396 (1998) 531-532
17. Qie M., Zhang Y., and Wu J. Study on the relationship between cervical cancer and p53 codon 72 polymorphism. Hua Xi Yi Ke Da Xue Xue Bao 33 (2002) 274-275
18. Wong Y.F., Chung T.K., Cheung T.H., Nobori T., Hampton G.M., Wang V.W., Li Y.F., and Chang A.M. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer. Gynecol. Obstet. Invest. 50 (2000) 60-63
19. Zhu Z.Z., Wang A.Z., Jia H.R., Jin X.X., He X.L., Hou L.F., and Zhu G. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn. J. Clin. Oncol. 37 (2007) 385-390
20. Li C.Y., Liu J.H., and Huang B.J. Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer. Ai Zheng 23 (2004) 1396-1399
21. Settheetham-Ishida W., Kanjanavirojkul N., Kularbkaew C., and Ishida T. Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol. Immunol. 49 (2005) 417-421
22. Muñoz N., Franceschi S., Bosetti C., Moreno V., Herrero R., Smith J.S., Shah K.V., Meijer C.J., and Bosch F.X. International Agency for Research on Cancer, Multicentric Cervical Cancer Study Group, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359 (2002) 1093-1101